Should you buy JNJ stock?
- EPS: US$1.93 (down from US$2.36 in 1Q 2021).
- Revenue: US$23.4b (up 5.0% from 1Q 2021).
- Net income: US$5.15b (down 17% from 1Q 2021).
- Profit margin: 22% (down from 28% in 1Q 2021). Higher expenses drove the decrease in the margin.
Is JNJ stock a buy or sell?
With a beta of 0.71, JNJ is the definition of a defensive stock. While strong share price growth should not be expected from this behemoth, when one also considers its status as a dividend aristocrat, as well as its sterling financial profile, JNJ stands out as a stock for risk averse investors. I rate JNJ as a BUY.
Why is JNJ stock falling?
Shares of Johnson & Johnson ( NYSE:JNJ) were sinking by 5.9% as of 3:31 p.m. EDT on Friday after the healthcare giant announced a recall of a single lot of its Johnson's Baby Powder. J&J stated in ...
Why did JNJ stock drop?
The healthcare giant is reportedly under investigation by the Department of Justice. Shares of Johnson & Johnson ( JNJ 0.96% ) closed down 4.15% on Friday after Bloomberg reported that the U.S. Department of Justice (DOJ) is investigating the healthcare conglomerate as to whether the company lied about possible cancer risks from its talcum powder.
See more
Is JNJ a Buy Sell or Hold?
For example, a stock trading at $35 with earnings of $3 would have an earnings yield of 0.0857 or 8.57%. A yield of 8.57% also means 8.57 cents of earnings for $1 of investment....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.75%2Buy18.15%3Hold9.70%4Sell5.35%2 more rows
Is JNJ a good stock to buy now?
JNJ delivered favorable financial results at the year-end of 2021, with its growth substantially larger than that of competitors. With its steadily growing EPS, the company's dividend yield of 2.57% stands significantly above the S&P 500 average of 1.57%, adding to the reasons why JNJ is a clear market favorite.
What is the target price for JNJ?
Stock Price TargetsHigh$215.00Median$187.00Low$174.00Average$188.29Current Price$171.69
Is JNJ overvalued?
The intrinsic value of one JNJ stock under the Base Case scenario is 138.42 USD. Compared to the current market price of 178.23 USD, Johnson & Johnson is Overvalued by 22%.
Is Johnson and Johnson going out of business?
J&J itself isn't bankrupt—instead, it has split off a new unit essentially designed to go broke paying legal liabilities. It's part of a maneuver to deal with about 38,000 lawsuits, mostly filed by women who claim one of the company's oldest products, baby powder, causes ovarian cancer.
Will JNJ ever split again?
The split isn't expected to happen until the end of 2023. Duato also told investors that the pandemic sped up trends like same-day delivery within the consumer health business.
How many times has Johnson and Johnson stock split?
According to our Johnson and Johnson stock split history records, Johnson and Johnson has had 6 splits.
What is the target price for Pfizer?
Stock Price TargetsHigh$75.00Median$55.00Low$43.00Average$55.95Current Price$51.37
Will PG stock go up?
The 21 analysts offering 12-month price forecasts for Procter & Gamble Co have a median target of 163.00, with a high estimate of 185.00 and a low estimate of 127.00. The median estimate represents a +13.23% increase from the last price of 143.96.
Why should I invest in Johnson and Johnson?
This marks the company's 60th consecutive yearly dividend increase. The company's efforts in growing its business through new innovative products and drugs are why I believe Johnson & Johnson is worth investing in. Its research and development expenses increased by 10% from the year-ago period to $3.4 billion in Q1.
Is Johnson and Johnson a good company?
Johnson & Johnson Named to Glassdoor's 2018 List of Best Places to Work Johnson & Johnson Named to Glassdoor's 2018 List of Best Places to Work. The company nabbed a top spot on the annual list—based entirely on positive reviews from its own employees.
Is Procter and Gamble a good stock to buy?
For this reason and more, P&G is arguably the best company in the Household Products industry. As a result, the stock has outperformed the market by a wide margin over the last year, and the company's brands are garnering a larger market share. P&G is also noted for performing well during market downturns.
What are Johnson and Johnson products?
Where is Johnson and Johnson located?
Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands ; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Ownership
- Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol \"JNJ.\" Johnson & Johnson's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.04%), Northern Trust Corp (1.30%), Boston Partners (0.46%), Sumitomo Mitsui Trust Holdings Inc. (0.41%), Swiss National Bank (0.37%) an…
Release
- Johnson & Johnson is scheduled to release their next quarterly earnings announcement on Tuesday, July 16th 2019. View Earnings Estimates for Johnson & Johnson.
Sales
- Johnson & Johnson issued an update on its FY19 earnings guidance on Tuesday, April, 16th. The company provided earnings per share (EPS) guidance of $8.53-8.63 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $8.59. The company issued revenue guidance of $80.4-81.2 billion, compared to the consensus revenue estimate of $81.17 …
Risks
- 11 brokerages have issued 1-year price targets for Johnson & Johnson's shares. Their forecasts range from $129.00 to $157.00. On average, they expect Johnson & Johnson's share price to reach $146.00 in the next year. This suggests a possible upside of 6.4% from the stock's current price. View Analyst Price Targets for Johnson & Johnson.
Ratings
- 11 Wall Street analysts have issued \"buy,\" \"hold,\" and \"sell\" ratings for Johnson & Johnson in the last year. There are currently 5 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of \"Buy.\" View Analyst Ratings for Johnson & Johnson.
Reviews
- News headlines about JNJ stock have been trending positive recently, InfoTrie Sentiment reports. The research firm rates the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Johnson & Johnson ea…
Business
- Johnson & Johnson has a market capitalization of $368.09 billion and generates $81.58 billion in revenue each year. The company earns $15.30 billion in net income (profit) each year or $8.18 on an earnings per share basis. Johnson & Johnson employs 135,100 workers across the globe.